Start:
April 2006
End:
September 2012
Enrollment:
272
The purpose of this study is to evaluate the efficacy of an enhanced consent procedure for patients with mild to moderate Alzheimer disease and to identify factors and patient characteristics that predict the degree to which enhanced consent is more beneficial than routine consent procedures.
Minimum Age: 50 Years
Maximum Age: N/A
++Clinical diagnosis of mild to moderate possible or probable AD or comparable healthy comparison subjects++Fluency in English++50 years and older++Informed written consent (or written assent with consent from legally authorized representative)
++Diagnosis of Lewy body dementia or mild cognitive impairment++Mini Mental State Exam score of less than 15++Physical or medical conditions that preclude participants from completing tasks++Neurologic or psychiatric condition that could impair neurocognitive functioning in healthy volunteers
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: National Institute on Aging (NIA)
Source: ClinicalTrials.gov ID: NCT00453544
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health